Bruix J, Sherman M. Management of hepatocellular carcinoma: An update. Hepatology. 2011;3:1020–1022.
Goldberg SN, Grassi CJ, Cardella JF, et al.
Image-guided tumor ablation: Standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2009;7
Hirooka M, Iuchi H, Kumagi T, et al.
Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography. AJR Am J Roentgenol. 2006;5
Rhim H, Lee MH, Kim YS, et al.
Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. AJR Am J Roentgenol. 2008;5:1324–1330.
Kitada T, Murakami T, Kuzushita N, et al.
Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas. Hepatol Res. 2008;6:565–571.
Minami Y, Kudo M, Chung H, et al.
Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Oncology. 2007;72:111–116.
Cho YK, Kim JK, Kim WT, et al.
Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: A Markov model analysis. Hepatology. 2010;4:1284–1290.
Molinari M, Helton S. Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: A Markov model decision analysis. Am J Surg. 2009;3:396–406.
Minami Y, Chung H, Kudo M, et al.
Radiofrequency ablation of hepatocellular carcinoma: Value of virtual CT sonography with magnetic navigation. AJR Am J Roentgenol. 2008;6:W335–W341.
Liu FY, Yu XL, Liang P, et al.
Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography. Eur J Radiol. 2012;7:1455–1459.
Nakai M, Sato M, Sahara S, et al.
Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography. Cardiovasc Intervent Radiol. 2009;1:62–9.
Lee MW, Rhim H, Cha DI, et al.
Percutaneous radiofrequency ablation of hepatocellular carcinoma: Fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. AJR Am J Roentgenol. 2012;6:1438–1444.
Livraghi T, Goldberg SN, Lazzaroni S, et al.
Hepatocellular carcinoma: Radio-frequency ablation of medium and large lesions. Radiology. 2000;3:761–768.
Zhou Y, Zhao Y, Li B, et al.
Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol. 2010;10:78.
Scaife CL, Curley SA. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin N Am. 2003;1:243–55.
Zhong Y, Deng M, Li M, et al.
Abdominal virtual sonography combined with artificial ascite in RFA for HCC of specific sites. Hepatol Int. 2013;7:1–9.
Llovet JM, Vilana R, Bru C, et al.
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;5:1124–1129.
Mulier S, Mulier P, Ni Y, et al.
Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;10:1206–1222.
de Villa V, Lo CM. Liver transplantation for hepatocellular carcinoma in Asia. Oncologist. 2007;11:1321–31.
McLernon DJ, Dillon J, Donnan PT. Health-state utilities in liver disease: A systematic review. Med Decis Making. 2008;4:582–592.
Stein K, Rosenberg W, Wong J. Cost effectiveness of combination therapy for hepatitis C: A decision analytic model. Gut. 2002;2:253–258.
Ruggeri M, Cicchetti A, Gasbarrini A. The cost-effectiveness of alternative strategies against HBV in Italy. Health Policy. 2011;1:72–80.
Gazelle GS, McMahon PM, Beinfeld MT, et al.
Metastatic colorectal carcinoma: Cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection. Radiology. 2004;3:729–739.
Peng ZW, Lin XJ, Zhang YJ, et al.
Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: A retrospective comparative study. Radiology. 2012;3:1022–1033.
Guan ZQ, Dong ZH, Wang QH, et al.
Cost of chronic hepatitis B infection in China. J Clin Gastroenterol. 2004;10
Chen D, Yao G, Chen W. Economic evaluation of peginterferon Alfa-2a and lamivudine in the treatment of HBeAg negative chronic hepatitis B. J Hepatol. 2014;4:1–9.
Chen JQ, Yang GH, Zhu Q, et al.
An analysis of related factors of cost of inpatients with hepatic carcinoma receiving operative treatment. Chinese Hospitals. 2003;12:1–9.
Huang J, Yan L, Cheng Z, et al.
A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;6:903–912.
Hung HH, Chiou YY, Hsia CY, et al.
Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol. 2011;1:79–86.
Vivarelli M, Guglielmi A, Ruzzenente A, et al.
Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg. 2004;1:102–107.
Eichler HG, Kong SX, Gerth WC, et al.
Use of cost-effectiveness analysis in health-care resource allocation decision-making: How are cost-effectiveness thresholds expected to emerge? Value Health. 2004;5:518–528.
Kawasoe H, Eguchi Y, Mizuta T, et al.
Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography. J Clin Biochem Nutr. 2007;1:66–72.